Lung Cancer PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Lung Cancer PDF full book. Access full book title Lung Cancer by Karen L. Reckamp. Download full books in PDF and EPUB format.
Author: Karen L. Reckamp
Publisher: Springer
ISBN: 3319403893
Category : Medical
Languages : en
Pages : 324
Get Book Here
Book Description
This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.
Author: Karen L. Reckamp
Publisher: Springer
ISBN: 3319403893
Category : Medical
Languages : en
Pages : 324
Get Book Here
Book Description
This book describes the molecular mechanisms of lung cancer development and progression that determine therapeutic interventions in the era of genomics, when the rapid evolution in lung cancer diagnosis and treatment necessitates critical review of new results to integrate advances into practice. The text opens with background and emerging information regarding the molecular biology of lung cancer pathogenesis. Updated results regarding lung cancer prevention and screening are discussed, followed by chapters on diagnostic techniques and pathological evaluation. This leads on to a detailed presentation of treatment modalities, from surgery and radiation therapy to standard chemotherapy and targeted agents. The coverage includes resistance to therapy and the emergence of immunotherapy for lung cancer; in addition, the current evidence in respect of small cell lung cancer is summarized. The book presents insights from experts across disciplines to emphasize the importance of collaborative care. Advances in our understanding of issues in geriatric oncology and palliative care complete the comprehensive discussion of lung cancer.
Author: Frank C. Detterbeck
Publisher: Saunders
ISBN:
Category : Medical
Languages : en
Pages : 512
Get Book Here
Book Description
Access comprehensive, multidisciplinary guidance on the diagnosis and treatment of lung cancer! This new resource addresses the full range of clinical issues in diagnosis, staging, and treatment, as well as the latest scientific data and evidence-based guidelines. A user-friendlyorganization provides quick reference to data summaries, as well as more comprehensive and detailed information for readers who wish to explore topics in depth. Features contributions by authors from many different disciplines, to ensure a balanced approach. Addresses the clinical issues seen in practice, with the inclusion of basic science research topics that are likely to be put into clinical practice soon. Integrates evidence-based medicine throughout. Assesses the strength of all available dataenabling readers to weigh different arguments and make decisions based on medical issues, values, and the availability and efficacy of interventionsusing a data rating system. Addresses difficult, but clinically relevant issues for which limited data is available. Enables readers to quickly reference findings and data in data summary statements and summary tables.
Author: Kemp H. Kernstine
Publisher: Demos Medical Publishing
ISBN: 1936287064
Category : Medical
Languages : en
Pages : 758
Get Book Here
Book Description
Over the course of the last decade, the treatment of lung cancer has evolved quite rapidly. New scientific and clinical advances have modified the standard of care and led to improved patient outcomes. At the same time, the treatment of lung cancer has become increasingly complex, requiring the comprehensive review and assessment of multiple issues, genetics, radiology, surgery, reconstruction, chemotherapy, and more. As a result the harmony and open communication between these specialties facilitated by a multidisciplinary team approach are crucial in providing the best care to patients and ensuring successful treatment. Written by a multidisciplinary team of authors representing a range of disciplines, is a valuable resource for physicians, fellows, nurses, physician assistants, physical therapists, and all health care providers involved in the treatment of lung cancer
Author: Noriaki Kurimoto
Publisher: John Wiley & Sons
ISBN: 1444347845
Category : Medical
Languages : en
Pages : 400
Get Book Here
Book Description
Endobronchial ultrasonography (EBUS) is an exciting new diagnostic tool that has added significantly to the diagnosis and staging of lung cancer and other thoracic diseases. This book is co-authored by one of the technology's pioneers and will help the reader to use EBUS to diagnose and stage lung cancer and a variety of different tumours of the chest region. Endobronchial Ultrasonography covers all of the standard techniques and the new developments involved in EBUS as it combines two common procedures, bronchoscopy and real-time ultrasonography. This allows physicians to obtain precise biopsies of lymph nodes and masses within the chest cavity. Over 250 high quality colour digital images are featured throughout the book to illustrate the different applications of EBUS, complemented by specific case studies. This book is accompanied by a companion website featuring over 30 video clips cited in the text.
Author: W.D. Travis
Publisher: Springer Science & Business Media
ISBN: 3642600492
Category : Medical
Languages : en
Pages : 139
Get Book Here
Book Description
with contributions by Pathologists from 14 Countries
Author: Frederick L, Greene
Publisher: Springer Science & Business Media
ISBN: 1475736568
Category : Medical
Languages : en
Pages : 386
Get Book Here
Book Description
The American Joint Committee on Cancer's Cancer Staging Manual is used by physicians throughout the world to diagnose cancer and determine the extent to which cancer has progressed. All of the TNM staging information included in this Sixth Edition is uniform between the AJCC (American Joint Committee on Cancer) and the UICC (International Union Against Cancer). In addition to the information found in the Handbook, the Manual provides standardized data forms for each anatomic site, which can be utilized as permanent patient records, enabling clinicians and cancer research scientists to maintain consistency in evaluating the efficacy of diagnosis and treatment. The CD-ROM packaged with each Manual contains printable copies of each of the book’s 45 Staging Forms.
Author: Imogen Evans
Publisher: Pinter & Martin Publishers
ISBN: 1905177488
Category : Health & Fitness
Languages : en
Pages : 187
Get Book Here
Book Description
This work provides a thought-provoking account of how medical treatments can be tested with unbiased or 'fair' trials and explains how patients can work with doctors to achieve this vital goal. It spans the gamut of therapy from mastectomy to thalidomide and explores a vast range of case studies.
Author: Lizza E.L Hendriks
Publisher: Frontiers Media SA
ISBN: 2889457079
Category :
Languages : en
Pages : 94
Get Book Here
Book Description
Approximately 40% of lung cancer patients will develop central nervous system (CNS) metastases during the course of their disease. Most of these are brain metastases, but up to 10% will develop leptomeningeal metastases. Known risk factors for CNS metastases development are small cell lung cancer (SCLC), adenocarcinoma histology, epidermal growth factor receptor (EGFR) mutant or anaplastic lymphoma kinase (ALK) rearranged lung cancer, advanced nodal status, tumor stage and younger age. CNS metastases can have a negative impact on quality of life (QoL) and overall survival (OS). The proportion of lung cancer patients diagnosed with CNS metastases has increased over the years due to increased use of brain imaging as part of initial cancer staging, advances in imaging techniques and better systemic disease control. Post contrast gadolinium enhanced magnetic resonance imaging (gd-MRI) is preferred, however when this is contra-indicated a contrast enhanced computed tomography (CE-CT) is mentioned as an alternative option. When CNS metastases are diagnosed, local treatment options consist of radiotherapy (stereotactic or whole brain) and surgery. Local treatment can be complicated by symptomatic radiation necrosis for which no high level evidence based treatment exists. Moreover, differential diagnosis with metastasis progression is difficult. Systemic treatment options have expanded over the last years. Until recently, chemotherapy was the only treatment option with a poor penetration in the CNS. Angiogenesis inhibitors are promising in the treatment of primary CNS tumors as well as radiation necrosis but clinical trials of anti-angiogenic agents in NSCLC have largely excluded patients with CNS metastases. Furthermore, research has also focused on methods to prevent development of CNS disease, for example with prophylactic cranial irradiation. Recently, checkpoint inhibitors have become available for NSCLC patients, and tyrosine kinase inhibitors (TKIs) have improved prognosis significantly in those with a druggable driver mutation. Newer TKIs are often designed to have better CNS penetration compared to first-generation TKIs. Despite advances in treatment options CNS metastases remain a problem in lung cancer and cause morbidity and mortality. This Research Topic provides an extensive resource of articles describing advances in CNS metastases management in lung cancer patients, from prevention to diagnosis and treatment.
Author: Goetz Kloecker
Publisher: McGraw Hill Professional
ISBN: 1260136213
Category : Medical
Languages : en
Pages : 509
Get Book Here
Book Description
An essential guide to the treatment and management of lung cancer Lung cancer remains the leading cause of cancer deaths worldwide, attributed mostly to environmental and behavioral factors. However, a diagnosis of lung cancer no longer means inevitable death. The new standards of care and a greater understanding of the etiology and biology of the disease has led to breakthroughs in patient survival rates that were not seen in the past. Standards of Care: Lung Cancer provides a solid foundation in the new principles approaching this disease. Presented in an accessible, quick-to-digest format, and written by leading experts in a variety of medical fields, this authoritative guide covers all the new procedures and treatment options and the latest advances in diagnosis and treatment, including immunotherapy and oncogene inhibition, and more. This is an essential resource for both practitioners and students studying for the boards or certification. Features Covers the most current treatments Continuous online updates on guidelines, new therapies, and studies Includes checklists, case studies, learning objectives, and clinical pearls Bibliography with listings of studies and trials Serves as an ideal resource for practice and board review
Author: Manfred Wagner
Publisher:
ISBN: 9783895999567
Category : Bronchoscopy
Languages : en
Pages : 96
Get Book Here
Book Description
At present lung cancer is the most common cancer in the world and responsible for over 1 million deaths worldwide. Advances in bronchoscopy have helped to increase detection rates of central type early lung cancer. These lesions are invisible on the basis of radiological methods. They usually show only subtle changes of the bronchial mucosa and are therefore sometimes difficult to identify by conventional bronchoscopy. The data showing the ability to increase the diagnostic rate for early lung cancer in the central airways by autofluorescence bronchoscopy are convincing. Video-chip-autofluorescence bronchoscopy seems to be one of the technologies with the largest impact on diagnostic bronchoscopy in the last decades.
